NightHawk lays off 14% of R&D work­force, piv­ots to fo­cus on CD­MO Scor­pius Bio­man­u­fac­tur­ing

NightHawk Bio­sciences laid off 14% of its work­force in R&D in or­der to fo­cus on its con­tract de­vel­op­ment and man­u­fac­tur­ing or­ga­ni­za­tion (CD­MO), just a lit­tle …

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER